PubRank

Yukio Ishii

Author PubWeight™ 35.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)-prostaglandin j(2). Mol Cell Biol 2004 2.25
2 Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema. Genes Cells 2005 2.18
3 Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. Clin Cancer Res 2009 2.04
4 Role of 15-deoxy delta(12,14) prostaglandin J2 and Nrf2 pathways in protection against acute lung injury. Am J Respir Crit Care Med 2005 1.94
5 Identification of polymorphisms in the promoter region of the human NRF2 gene. Biochem Biophys Res Commun 2004 1.40
6 Suppression of eosinophilic airway inflammation by treatment with alpha-galactosylceramide. Eur J Immunol 2005 1.22
7 Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance. Respir Res 2010 1.21
8 Impact of global warming on a group of related species and their hybrids: cherry tree (Rosaceae) flowering at Mt. Takao, Japan. Am J Bot 2007 1.11
9 A patient with pulmonary lymphangitic carcinomatosis successfully treated with TS-1 and cisplatin. Intern Med 2007 1.10
10 Transcription factors GATA-3 and RORγt are important for determining the phenotype of allergic airway inflammation in a murine model of asthma. J Immunol 2013 1.09
11 Transcription factors T-bet and GATA-3 regulate development of airway remodeling. Am J Respir Crit Care Med 2006 1.03
12 Role of Nrf2 in host defense against influenza virus in cigarette smoke-exposed mice. J Virol 2011 1.01
13 Treatment with alpha-galactosylceramide attenuates the development of bleomycin-induced pulmonary fibrosis. J Immunol 2004 0.98
14 Association of phosphodiesterase 4D gene polymorphisms with chronic obstructive pulmonary disease: relationship to interleukin 13 gene polymorphism. Int J Mol Med 2006 0.96
15 Polymorphisms of TNFalpha, IL1beta, and IL1RN genes in chronic obstructive pulmonary disease. Biochem Biophys Res Commun 2005 0.93
16 Overexpression of the transcription factor GATA-3 enhances the development of pulmonary fibrosis. Am J Pathol 2006 0.90
17 Niflumic acid and AG-1478 reduce cigarette smoke-induced mucin synthesis: the role of hCLCA1. Chest 2007 0.87
18 Anti-inflammatory activity of creatine supplementation in endothelial cells in vitro. Br J Pharmacol 2003 0.86
19 Involvement of thromboxane A(2) in airway mucous cells in asthma-related cough. J Appl Physiol (1985) 2002 0.85
20 Overexpression of RORγt under control of the CD2 promoter induces polyclonal plasmacytosis and autoantibody production in transgenic mice. Eur J Immunol 2012 0.85
21 Impairment of host defense against disseminated candidiasis in mice overexpressing GATA-3. Infect Immun 2010 0.84
22 Spontaneous pneumomediastinum after air travel. Am J Emerg Med 2008 0.84
23 SQSTM1/p62/A170 regulates the severity of Legionella pneumophila pneumonia by modulating inflammasome activity. Eur J Immunol 2014 0.82
24 MMP14 gene polymorphisms in chronic obstructive pulmonary disease. Int J Mol Med 2006 0.81
25 Aggravation of bleomycin-induced pulmonary inflammation and fibrosis in mice lacking peroxiredoxin I. Am J Respir Cell Mol Biol 2011 0.81
26 IL-17F Induces CCL20 in Bronchial Epithelial Cells. J Allergy (Cairo) 2011 0.81
27 Carbocisteine reduces virus-induced pulmonary inflammation in mice exposed to cigarette smoke. Am J Respir Cell Mol Biol 2014 0.81
28 The effect of smoking-related hyperhomocysteinemia on spirometric declines in chronic obstructive pulmonary disease in elderly Japanese. Arch Gerontol Geriatr 2005 0.80
29 Overexpression of GATA-3 protects against the development of hypersensitivity pneumonitis. Am J Respir Crit Care Med 2007 0.80
30 Role of Th1/Th17 balance regulated by T-bet in a mouse model of Mycobacterium avium complex disease. J Immunol 2014 0.80
31 Promoter activity of human tissue inhibitor of metalloproteinase 2 gene with novel single nucleotide polymorphisms. Respirology 2005 0.78
32 Upper lobe-dominant pulmonary fibrosis showing deposits of hard metal component in the fibrotic lesions. Intern Med 2010 0.78
33 Sputum E-cadherin and asthma severity. J Allergy Clin Immunol 2003 0.77
34 Serum KL-6 levels and acute lung inflammation. Intern Med 2007 0.75
35 [Sarcoidosis presenting after successful treatment for Cushing syndrome]. Nihon Kokyuki Gakkai Zasshi 2009 0.75
36 Sleep stage determines the expression pattern of sleep apneas. Intern Med 2007 0.75
37 Quinupristin/dalfopristin and voriconazole controlled Staphylococcus epidermidis pneumonia and chronic necrotizing aspergillosis in a patient with severe lung degradation consequent to multiple treatments for Hodgkin's lymphoma. J Infect Chemother 2007 0.75
38 Defecation-related asthma. Intern Med 2013 0.75
39 Mismatch between gallium-67 uptake and CT findings in a case of pulmonary alveolar proteinosis. Ann Nucl Med 2005 0.75
40 Broncho-bronchiolitis obliterans after living-donor lung transplantation: a unique manifestation of chronic allograft rejection. Transplantation 2013 0.75
41 [Syndrome of inappropriate secretion of ADH following chemoradiation therapy]. Gan To Kagaku Ryoho 2012 0.75
42 Targeting Th2 cytokines in fibrotic diseases. Curr Opin Investig Drugs 2010 0.75
43 Synthetic double-stranded RNA induces interleukin-32 in bronchial epithelial cells. Exp Lung Res 2015 0.75
44 Effect of inhaled steroids on increased collagen synthesis in asthma. Respiration 2006 0.75
45 Cysteinyl leukotrienes and collagen type I synthesis in asthma. J Allergy Clin Immunol 2004 0.75